WASHINGTONPOST (Dan Diamond) - Democrats again demand Trump’s drug-price contracts following Post report
Lawmakers say they cannot judge the effectiveness of the administration’s initiative to lower drug prices until the contracts are released.
Filters Applied:
Lawmakers say they cannot judge the effectiveness of the administration’s initiative to lower drug prices until the contracts are released.
Vice President JD Vance said the move will save $2.2 billion by preventing "rampant" fraud.
Vice President JD Vance said the measure would save the government $2.2 billion.
Vice President JD Vance said the measure would save the government $2.2 billion.
Gov. JB Pritzker of Illinois, widely seen as a potential presidential candidate, revealed in an interview on “CBS Mornings” that he had been on a GLP-1 regimen since 2024.
| Keywords | jb-pritzkerillinoisglp-1ozempicweight-losshealthmedicareelection-2028politicsmedicinewellnesslifestylebiotechnologybig-pharmacms |
The Trump administration claims that Medicaid will save billions on prescription drug costs as a result of the plan.
The CBO estimates 5.3 million more people will be uninsured in 2034 because of a new Medicaid work requirement. Life is getting more expensive. What’s next? Stream CNN Breaks It Down for answers on the CNN app: https://cnn.it/4bZ6MRr #News
There are troubling new signs that the overhaul of Medicare drug coverage in the Inflation Reduction Act is dramatically driving up program spending. Why it matters: The upward trajectory could threaten some seniors' coverage for outpatient prescription drugs — and it could force painful tradeoffs over the next decade as Medicare consumes a growing share of the nation's debt. Follow the money: The IRA limited what seniors have to pay for outpatient drugs and shifted the remaining cost to taxpayers, insurers who provide stand-alone Medicare drug plans and drug manufacturers. - That was good news for enrollees who take expensive drugs for conditions like cancer, multiple sclerosis or rheumatoid arthritis and faced potentially crushing…
On Monday, President Donald Trump announced a new set of deals with nine pharmaceutical companies to lower drug prices. Under the deals, the companies offer discounts to state Medicaid programs on certain drugs to bring their prices in line with the amounts charged in other developed countries.
Nine more pharmaceutical companies said they would cut the prices on some drugs through Trump’s Most Favored Nation program.
| Keywords | trumphealthcaredrug-pricesmost-favored-nationpharmaceuticalsdonald-trumpeconomymedicationprescription-drugspolicyus-politicsadministrationcmshhsmedicarecongresscost-savingselection-2026usa |